If you need more lookups,
subscriptions start at $34 USD/month.
Ross Murdoch Location
Melbourne, VIC, AU
Ross Murdoch Work
Non Executive Director @ (May 2026 - Present)
CEO @ (June 2019 - Present)
Non Executive Director @ Avecho Biotechnology Limited (formerly Phosphagenics Limited) (May 2019 - Present)
CEO @ Avecho Biotechnology Limited (formerly Phosphagenics Limited) (January 2015 - April 2019)
Pharmaceutical and Healthcare consultant @ Consultant (October 2012 - December 2014)
Senior Vice President: Hematology @ (September 2010 - October 2012)
Senior Vice President: Emerging Business Unit @ (June 2007 - August 2010)
President and COO @ Prana Biotechnology Ltd (May 2002 - May 2007)
Head Project Management @ (January 1998 - January 2001)
Project Director @ SmithKline Beecham (January 1995 - January 1997)
Ross Murdoch Education
University of Melbourne
PhD (Clinical Pharmacology)
1987-1991
Monash University
BSc (hons) (Science)
1983-1986
Ross Murdoch Skills
Biopharmaceuticals
Biotechnology
Business Development
Clinical Development
Clinical Trials
Cross-functional Team Leadership
Dermatology
Drug Development
Executive Team
Healthcare
Life Sciences
Lifesciences
Neurology
Non-Executive Director
Oncology
Pharmaceutical Industry
Pharmaceutical Sales
Pharmaceutics
Regulatory Affairs
Sales Effectiveness
Technology Transfer
Cross Functional Team Leadership
Microsoft Excel
Strategy
Customer Service
Ross Murdoch Summary
Ross Murdoch, based in Melbourne, VIC, AU, is currently a Non Executive Director at Neurizon Therapeutics Limited. Ross Murdoch brings experience from previous roles at Tasmanian Alkaloids Pty Ltd., Avecho Biotechnology Limited (formerly Phosphagenics Limited) and Consultant. Ross Murdoch holds a 1987 - 1991 PhD in Clinical Pharmacology @ University of Melbourne. With a robust skill set that includes Biopharmaceuticals, Biotechnology, Business Development, Clinical Development, Clinical Trials and more. Ross Murdoch has 2 emails on RocketReach.
Looking for a different Ross Murdoch?
Find contact details for 700 million professionals.